Variation in the genetic environments of blaCTX-M-15 in Escherichia coli from the faeces of travellers returning to the United Kingdom

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 5, 2011, Pages 1005-1012

  Dhanji, Hiran ^a   Patel, Rajesh ^b   Wall, Robert ^b   Doumith, Michel ^a   Patel, Bharat ^b   Hope, Russell ^a   Livermore, David M ^a   Woodford, Neil ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

CTX M 15 ESBL; IS26; ISEcp1; Promoter

Indexed keywords

AGAR; AMIKACIN; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 15; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DIARRHEA; DNA SEQUENCE; ESCHERICHIA COLI; FECES ANALYSIS; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; TRAVEL; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BLOTTING, NORTHERN; CEFUROXIME; CLONING, MOLECULAR; CULTURE MEDIA; DIARRHEA; DNA, BACTERIAL; ESCHERICHIA COLI; FECES; HUMANS; LONDON; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRAVEL;

EID: 79954586105     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr041     Document Type: Article

References (29)

1. Canton R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006; 9: 466-75.
2. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-81.
3. Pitout JD, Gregson DB, Campbell L et al. Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2009; 53: 2846-51.
4. Rooney PJ, O'Leary MC, Loughrey AC et al. Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacinresistant Escherichia coli. J Antimicrob Chemother 2009; 64: 635-41.
5. Rodriguez-Bano J, Lopez-Cerero L, Navarro MD et al. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008; 62: 1142-9.
6. Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-43.
7. Lau SH, Kaufmann ME, Livermore DM et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 β-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 2008; 62: 1241-4.
8. Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother 2006; 57: 14-23.
9. Lavollay M, Mamlouk K, Frank T et al. Clonal dissemination of a CTX-M-15 β-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob Agents Chemother 2006; 50: 2433-8.
10. Boyd DA, Tyler S, Christianson S et al. Complete nucleotide sequence of a 92-kilobase plasmid harbouring the CTX-M-15 extended-spectrum β-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004; 48: 3758-64.
11. Woodford N, Carattoli A, Karisik E et al. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother 2009; 53: 4472-82.
12. Pitout JD, Campbell L, Church DL et al. Molecular characteristics of travel-related extended-spectrum-β-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrob Agents Chemother 2009; 53: 2539-43.
13. Tangden T, Cars O, Melhus A et al. Foreign travel is a major risk factor for colonization with Escherichia coli producing extended-spectrum β-lactamases of the CTX-M type: a prospective study on Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-8.
14. Laupland KB, Church DL, Vidakovich J et al. Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 2008; 57: 441-8.
15. Tham J, Odenholt I, Walder M et al. Extended-spectrum β-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis 2010; 2: 275-80.
16. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48: 5-16.
17. BSAC Methods for Antimicrobial susceptibility testing http://www.bsac.org.uk/_db/_documents/Version_9.1_March_2010_final.pdf (27 August 2010, date last accessed).
18. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 2006; 57: 154-5.
19. Poirel L, Gniadkowski M, Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J Antimicrob Chemother 2002; 50: 1031-4.
20. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
21. Dhanji H, Doumith M, Clermont O et al. Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extendedspectrum β-lactamases. Int J Antimicrob Agents 2010; 36: 355-8.
22. Karim A, Poirel L, Nagarajan S et al. Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Letters 2001; 201: 237-41.
23. Soft berry Promoter analysis software. http://linux1.softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=gfindb.8-11-0010 (27 August 2010, date last accessed).
24. Poirel L, Lartigue MF, Decousser JW et al. ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli. Antimicrob Agents Chemother 2005; 49: 447-50.
25. Bae IK, Lee BH, Hwang HY et al. A novel ceftazidime-hydrolysing extended-spectrum β-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop. J Antimicrob Chemother 2006; 58: 315-9.
26. Celenza G, Pellegrini C, Caccamo M et al. Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother 2006; 57: 975-8.
27. Suzuki S, Shibata N, Yamane K et al. Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2009; 63: 72-9.
28. Mohamed Al-Agamy MH, El-Din Ashour MS, Wiegand I. First description of CTX-M β-lactamase-producing clinical Escherichia coli isolates from Egypt. Int J Antimicrob Agents 2006; 27: 545-8.
29. Murk JL, Heddema ER, Hess DLJ et al. Enrichment broth improved detection of extended-spectrum-β-lactamase-producing bacteria in throat and rectal surveillance cultures of samples from patients in intensive care units. J Clin Microbiol 2009; 47: 1885-7.